Thyroid disorder Board decisions

The Board has denied the Veteran's claims for service connection for primary amyloidosis, patchy alveolar condition, duodenal mass condition, thyroid condition, and myeloma. The evidence does not support a finding of current disabilities for any of these conditions.

The Veteran's claim for service connection for hypothyroidism is granted due to the submission of new evidence showing a thyroid disorder began in service. The Board finds that direct service connection for a thyroid disorder is warranted, and the presumption for herbicide-exposed Veterans has been rebutted.

The Board has dismissed all issues of service connection as the Veteran died during the appeal process.

The Veteran's claim for a compensable rating for service-connected hypothyroidism was denied as there were no current findings, signs, or symptoms attributable to the condition.

Your claims for service connection for thyroid carcinoma and hepatitis C have been dismissed due to the Veteran's death.

The Board has determined that the Veteran's hyperthyroidism may be related to his service in a toxic risk exposure activity (TERA) and remands for further examination and opinion.

The Veteran's sleep apnea and hypothyroidism (previously rated as hyperthyroidism) have been granted service connection, with the rating for hypothyroidism restored to 30 percent effective October 17, 2017.

The Veteran's hypothyroidism was not diagnosed within the past six months and has not resulted in myxedema or other symptoms. The Veteran's symptoms are attributed to his service-connected PTSD, resulting in a denial of a compensable rating for hypothyroidism.

The Board has granted service connection for thyroid cancer, rib cancer as a complication of thyroid cancer, and peripheral vestibular disorder as a complication of thyroid cancer. The decision is based on the Veteran's exposure to Agent Orange during his military service.

The Board has remanded the Veteran's claims for service connection due to his exposure to toxic substances during military service, including in Southwest Asia and at Fort McClellan. The VA examiners did not adequately address the Veteran's contentions regarding his hazardous exposures.

The Board has granted service connection for hypothyroidism as a complication of the Veteran's service-connected thyroid cancer.

The Veteran's claim for service connection for hypothyroidism is being remanded due to the need for a medical examination and opinion regarding the nature and etiology of her diagnosed condition.

The Board has granted an initial 30 percent rating for hypothyroidism from February 24, 2021, to June 9, 2021. The Veteran's right knee and bilateral foot pain issues are remanded due to inadequate examination.

The Veteran's prostate cancer, hypothyroidism, and diabetes mellitus, type II are presumed to be caused by exposure to herbicide agents during service.

The Veteran's initial compensable rating for service-connected hypothyroidism was denied as there were no signs or symptoms of the condition during the appeal period, and the evidence did not support a higher rating.

The Veteran's claim for an increased rating for her medullary thyroid cancer was granted with an effective date of June 11, 2020.

The Veteran's appeal for service connection for depression, a neck condition, thyroid condition, hypertension and sleeping conditions has been dismissed due to the withdrawal of the appeal by the Veteran's representative.

Effective June 29, 2021, the Veteran's diabetes mellitus, type II and hypothyroidism have been granted as secondary to Agent Orange exposure.,Effective June 29, 2021, the Veteran's diabetic neuropathy of various extremities and diabetic nephropathy are also granted as secondary to his diabetes mellitus, type II.

The Veteran's initial claim for an initial compensable rating for hypothyroidism is being remanded due to a failure to obtain relevant private treatment records. The AOJ will need to request these records from the identified providers and facilities.

The Board has dismissed the appeals for service connection for thyroid cancer, bilateral hearing loss, and tinnitus as they have already been adjudicated in previous decisions.